Seizure Detection News
-
Showcase
Neeuro (Singapore) and epihunter (Belgium) partner to create new and innovative digital solutions for people with brain disorders
On March 15th 2015, Tim Buckinx’ son said: “Papa, you work in digital, can’t you create a light that turns on when my brain switches off?” At ten years old, he was simply fed up with the daily impact of his refractory epilepsy. That pain became a vision, and that vision became the Belgian digital therapeutics company epihunter, aimed at enabling people with a brain ...
By Epihunter NV
-
Showcase
Empatica Announces EmbracePlus: NASA Medical Quality in a Down-to-Earth Smart Watch
BOSTON, Nov. 19, 2019 /PRNewswire/ -- On November 19th, 2019, Empatica is announcing EmbracePlus, their new smart watch built in partnership with TRISH, the Translational Research Institute for Space Health. NASA's Human Research Program partners with external entities to develop new approaches that can help reduce the risk to humans on long exploration missions. One such entity is TRISH, who ...
-
Beacon Biosignals announces partnership with Stratus to advance at-home brain monitoring and machine learning-enabled neurodiagnostics
Beacon Biosignals, which applies AI to EEG to unlock precision medicine for brain conditions, today announced a partnership with Stratus, the nation's leading provider of EEG services, to enable expanded clinical trial service capabilities by leveraging Beacon's machine learning neuroanalytics platform. EEG is standard of care in the clinical diagnosis and management of many neurologic diseases ...
-
NeuroSigma Receives FDA Breakthrough Device Designation for Monarch eTNS System®
NeuroSigma, Inc., a bioelectronic medical device company, today announced FDA Breakthrough Device Designation for its Monarch eTNS System® for “adjunctive use for reducing the frequency of seizures in individuals 18 years of age or older diagnosed with epilepsy characterized by partial-onset seizures, with or without secondary generalization, that are refractory to two or more ...
-
Faster & Better EEG Tests with Zeto Health Technology Podcast with Aswin Gunasekar, CEO & Founder, Zeto
For the August installment of the Healthtech Leader of the Month series, we interviewed Aswin Gunasekar, founder and CEO of Zeto. Zeto is a device-driven platform for acquiring, accessing, and interpreting electroencephalograms (EEGs). An EEG is a test used to evaluate electrical activity in the ...
By Zeto, Inc.
-
CBD For Beginners: Everything you should Know About Cannabidiol
CBD For Beginners: Everything You Should Know About Cannabidiol You have likely already heard about the many potential benefits of including CBD in your wellness routine, but the idea of approaching CBD for beginners can be a little daunting. What is CBD? Is it addictive? How will it affect my body, and how is it consumed? For anyone just now considering CBD, there are tons of questions you may ...
By Medcbdx
-
Wireless EEG for Fast Prep and Easy Use: Q&A with Aswin Gunasekar, CEO of Zeto
Electroencephalography (EEG) devices are incredibly helpful in diagnosing and monitoring certain brain disorders, such as epilepsy and strokes. However, they are not particularly user-friendly or convenient, with specialized technicians performing time consuming procedures, such as skin preparation, to get patients ready to undergo the procedure. A combination of messy gels and wires also makes ...
By Zeto, Inc.
-
Worldwide first absence seizure tracker becomes available to Australian families
More than 250,000 people are living with epilepsy in Australia, of which 1 in 7 are having difficult-to-notice absence seizures. Such seizures are different from tonic-clonic (convulsive) seizures, and are typically shorter in length, with a brief loss of consciousness. Even though this type of seizure usually does not lead to physical injury, it has a major impact on the wellbeing of the person ...
By Epihunter NV
-
Brain Sentinel Announces Satellite Symposium at AES Annual Meeting in Baltimore, Maryland
Brain Sentinel, Inc. announces it is hosting a non-CME satellite symposium for healthcare professionals in Baltimore, Maryland at the AES Annual Meeting. The symposium, “Fundamentals of Quantitative Surface Electromyography (sEMG) for Long-Term Monitoring”, has 5 key learning objectives: Understand methods of quantitative sEMG analysis during ictal events; Review specific sEMG ...
-
Epihunter awarded $200k grant to support the commercialization of its AI seizure detection algorithm
Belgian health tech startup epihunter NV is awarded a $200,000 grant from Epilepsy Foundation to further validate and market their CE labelled epileptic seizure detection algorithm. “The objective seizure data collected by epihunter can help clinicians make more informed treatment decisions,” says Dr Alexander Rotenberg, neurologist at Boston Children’s Hospital and ...
By Epihunter NV
-
Belgian healthtech startup, epihunter, launches second breakthrough for absence epilepsy
“Including video in epileptic seizure detection has the potential to change the way neurologists and epileptologists assess and document seizure frequency and the effect of therapy,” says Dr Sándor Beniczky, Head of Clinical Neurophysiology at the Danish Epilepsy Centre. It is estimated that 1 in 100 people have epilepsy, and 1 in 3 people with epilepsy continue to experience ...
By Epihunter NV
-
Belgian healthtech startup, epihunter, launches second breakthrough for absence epilepsy
Belgian startup, epihunter, introduces automated video functionality to their CE-marked seizure detection app - a breakthrough for children and adults with epilepsy, their families and doctors. “Including video in epileptic seizure detection has the potential to change the way neurologists and epileptologists assess and document seizure frequency and the effect of therapy,” says Dr ...
By Epihunter NV
-
Brain Sentinel, Inc. Announces New FDA 510(k) Clearance for its First-in-Class SPEAC® System Helping Physicians Characterize Seizure Events
Brain Sentinel, Inc., manufacturer of the first FDA-cleared portable seizure monitoring and alerting technology utilizing surface electromyography (sEMG), announced that its SPEAC® System has received a new 510(k) clearance of expanded indications from the U.S. Food and Drug Administration (FDA). Brain Sentinel, Inc., manufacturer of the first FDA-cleared portable seizure monitoring ...
-
Brain Sentinel Diagnostic Services LLC Receives Innovative Technology Contract from Vizient for the SPEAC System
Brain Sentinel Diagnostic Services LLC announced that it has received an Innovative Technology contract from Vizient, Inc., the largest member-driven health care performance improvement company in the country. Brain Sentinel Diagnostic Services is an independent diagnostic testing facility that provides the SPEAC® System. The new multi-year contract began in April 2019 and is based on a ...
-
Brain Sentinel Announces Launch of SeizureLink, its sEMG-Based Seizure Alerting System, Available Without a Prescription
Brain Sentinel Consumer Systems, LLC (herein “Brain Sentinel”) announces the global launch of its new SeizureLink™ Alerting System at the Epilepsy Foundation’s “2018 Epilepsy Pipeline Conference”, currently being held in San Francisco, CA. Pre-ordering for the U.S. will begin in March 2018, with shipments planned to begin by mid-summer via SeizureLink.com. ...
-
Brain Sentinel, Inc. Announces the Purchase of IctalCare A/S Assets
Brain Sentinel, Inc., a Texas company, has purchased the assets of IctalCare A/S, a Danish company. These assets include intellectual property, and a non-prescription, wearable device designed to monitor for seizure activity. "We are excited to add to our product line a small, wearable surface electromyography (sEMG) monitor that consumers may order and use without a prescription," said Mike ...
-
Brain Sentinel’s SPEAC® System Named `Best of What’s New` for 2017 by Popular Science Magazine
Popular Science magazine has named the SPEAC® System "Best of What’s New in 2017" in the Health category. The SPEAC® System is the first FDA-cleared, non-EEG, physiological, signal-based system for seizure monitoring. "We are excited and thrilled by this award from Popular Science," said Mike Girouard, President, CEO and co-founder of Brain Sentinel, Inc. Girouard ...
-
Brain Sentinel’s SPEAC® System Demonstrates Equivalence in Sensitivity to Detect Generalized Tonic Clonic Seizures to Video EEG
Brain Sentinel’s SPEAC® System demonstrated equivalence with the gold standard, video EEG, in detecting generalized tonic-clonic seizures (GTCS) using surface electromyography (sEMG). In a new study published on October 5, 2017, in the medical journal, Epilepsia, Brain Sentinel’s SPEAC® System which uses the surface electromyography (sEMG) biomarker demonstrated ...
-
Metaglut1, A New Diagnostic Test for the Glut1 Deficiency Syndrome
Laboratoire Cerba and METAFORA biosystems are proud to announce the availability of the innovative test METAglut1 in routine biology to help diagnose the GLUT1 deficiency syndrome (GLUT1-DS) Laboratoire Cerba will perform the METAglut1 diagnostics test developed by METAFORA for the early non-invasive diagnosis of a debilitating neurological disease, the GLUT1 deficiency syndrome (also named De ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you